Tilo Breidert

1.2k total citations
9 papers, 1.0k citations indexed

About

Tilo Breidert is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Tilo Breidert has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Tilo Breidert's work include Drug Transport and Resistance Mechanisms (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Tilo Breidert is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Tilo Breidert collaborates with scholars based in Germany, France and United States. Tilo Breidert's co-authors include Étienne C. Hirsch, Estelle Rousselet, Patrick P. Michel, Jean‐Marie Launay, Stéphane Hunot, A. Hartmann, Michael T. Heneka, Gary E. Landreth, Jacques Callebert and Folker Spitzenberger and has published in prestigious journals such as Journal of Biological Chemistry, Annals of the New York Academy of Sciences and Journal of Neurochemistry.

In The Last Decade

Tilo Breidert

9 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tilo Breidert Germany	8	404	397	348	301	190	9	1.0k
Nina Vartiainen Finland	15	400 1.0×	437 1.1×	208 0.6×	239 0.8×	172 0.9×	16	1.0k
Rosa M. Solano Spain	19	647 1.6×	562 1.4×	530 1.5×	179 0.6×	364 1.9×	42	1.5k
Giulia Ambrosi Italy	17	294 0.7×	347 0.9×	324 0.9×	124 0.4×	175 0.9×	26	941
T Nagatsu Japan	21	366 0.9×	305 0.8×	319 0.9×	134 0.4×	91 0.5×	46	998
F. L. Van Muiswinkel Netherlands	18	327 0.8×	468 1.2×	294 0.8×	377 1.3×	339 1.8×	33	1.2k
David S. Albers United States	24	966 2.4×	716 1.8×	803 2.3×	401 1.3×	464 2.4×	34	2.1k
Isabel Hervías Spain	15	244 0.6×	411 1.0×	220 0.6×	107 0.4×	151 0.8×	19	864
B. B. Mršulja Romania	16	546 1.4×	460 1.2×	287 0.8×	323 1.1×	283 1.5×	57	1.3k
Henryk Jęśko Poland	23	190 0.5×	735 1.9×	165 0.5×	178 0.6×	417 2.2×	42	1.4k
Jun‐ichi Kakimura Japan	14	252 0.6×	437 1.1×	210 0.6×	158 0.5×	235 1.2×	21	870

Countries citing papers authored by Tilo Breidert

Since Specialization

Citations

This map shows the geographic impact of Tilo Breidert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilo Breidert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilo Breidert more than expected).

Fields of papers citing papers by Tilo Breidert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilo Breidert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilo Breidert. The network helps show where Tilo Breidert may publish in the future.

Co-authorship network of co-authors of Tilo Breidert

This figure shows the co-authorship network connecting the top 25 collaborators of Tilo Breidert. A scholar is included among the top collaborators of Tilo Breidert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilo Breidert. Tilo Breidert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Weinmann, Stefan, et al.. (2019). Klinische Wirksamkeit von „FlexiTeam“ (Home Treatment und intensivierte ambulante Behandlung) – Vergleich einer Behandlung in einem Modellprojekt nach § 64b in Berlin mit der stationären Behandlung. Psychiatrische Praxis. 46(5). 249–255. 10 indexed citations

Takahashi‐Fujigasaki, Junko, Tilo Breidert, Hiroto Fujigasaki, et al.. (2010). Amyloid precursor-like protein 2 cleavage contributes to neuronal intranuclear inclusions and cytotoxicity in spinocerebellar ataxia-7 (SCA7). Neurobiology of Disease. 41(1). 33–42. 5 indexed citations

Lacombe, Pierre, Paul M. Mathews, Stephen D. Schmidt, et al.. (2004). Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised.. Journal of Neuroinflammation. 1(1). 11–11. 41 indexed citations

Hirsch, Étienne C., Tilo Breidert, Estelle Rousselet, et al.. (2003). The Role of Glial Reaction and Inflammation in Parkinson's Disease. Annals of the New York Academy of Sciences. 991(1). 214–228. 366 indexed citations

Hirsch, Étienne C., Günter U. Höglinger, Estelle Rousselet, et al.. (2003). Animal models of Parkinson’s disease in rodents induced by toxins: an update. Journal of neural transmission. Supplementum. 89–100. 74 indexed citations

Breidert, Tilo, Jacques Callebert, Michael T. Heneka, et al.. (2002). Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease. Journal of Neurochemistry. 82(3). 615–624. 322 indexed citations

Gründemann, Dirk, Sandra Köster, Nicholas Kiefer, et al.. (1998). Transport of Monoamine Transmitters by the Organic Cation Transporter Type 2, OCT2. Journal of Biological Chemistry. 273(47). 30915–30920. 128 indexed citations

Breidert, Tilo, Folker Spitzenberger, Dirk Gründemann, & Edgar Schömig. (1998). Catecholamine transport by the organic cation transporter type 1 (OCT1). British Journal of Pharmacology. 125(1). 218–224. 73 indexed citations

Gründemann, Dirk, Tilo Breidert, Folker Spitzenberger, & Edgar Schömig. (1997). Molecular Structure of the Caronrier Responsible for Hepatic Uptake of Catecholamines. Advances in pharmacology. 42. 346–349. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact